Invesaro

Stocks Health care TLRY

NASDAQ · Health care

Tilray Brands, Inc. (TLRY)

Tilray Brands, Inc. reported revenue of $915.5M in fiscal 2026, up 11.5% from a year earlier. It posted a net loss of $121.4M. At May 31, 2026 it held $226M in cash. Its latest periodic report to the SEC is the annual report (10-K) filed on July 28, 2026.

Price
$4.13
+1.47% on the day · September 25, 2026
52-week range $3.67 to $23.20
Market cap
$481.2M
Revenue (FY2026)
$915.5M
+11.5% year on year
Net margin
-13.3%

What Tilray Brands, Inc. does

Tilray Brands, Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on NASDAQ under the ticker TLRY.

Revenue and profit by year

Revenue
FY21: $405.3M $405.3M FY21FY20: $210.5M $210.5M FY20FY21: $513.1M $513.1M FY21FY22: $628.4M $628.4M FY22FY23: $627.1M $627.1M FY23FY24: $788.9M $788.9M FY24FY25: $821.3M $821.3M FY25FY26: $915.5M $915.5M FY26
Net income
FY21: -$102.5M -$102.5M FY21FY20: -$271.1M -$271.1M FY20FY21: -$367.4M -$367.4M FY21FY22: -$476.8M -$476.8M FY22FY23: -$1.5B -$1.5B FY23FY24: -$245M -$245M FY24FY25: -$2.2B -$2.2B FY25FY26: -$121.4M -$121.4M FY26

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2026$915.5M-$63M-$121.4M-$1.09n/a
2025$821.3M-$2.3B-$2.2B-$24.56-$127.5M
2024$788.9M-$174.7M-$245M-$3.30-$60.2M
2023$627.1M-$1.4B-$1.5B-$23.50-$12.9M
2022$628.4M-$610.4M-$476.8M-$9.90-$211.3M
2021$513.1M-$132.2M-$367.4M-$13.60-$83.6M
Next report expected around October 8, 2026.

Estimated from its filing rhythm: 52 weeks after its report of October 9, 2025. Not a date the company has announced. See the report calendar

Where TLRY ranks in Health care

Revenue$915.5M
#151 of 523 in Health care · Top 29%
Revenue growth+11.5%
#234 of 437 in Health care · Bottom 47%
Net margin-13.3%
#256 of 447 in Health care · Bottom 43%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Tilray Brands, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 18, 2026
  2. September 14, 2026
  3. August 10, 2026
  4. July 31, 2026
  5. July 28, 2026
    Annual report 10-K · period to May 31, 2026
  6. July 28, 2026
  7. June 30, 2026
  8. June 9, 2026
  9. April 21, 2026
  10. April 21, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on August 27, 2026. Insider transactions on SEC

Insider trades

What the people running Tilray Brands, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider bought or sold shares on the open market in the last 90 days. The 16 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
August 26, 2026 Faltischek Denise MChief Strategy Officer Exercised options 58,204 - - Form 4
August 26, 2026 Faltischek Denise MChief Strategy Officer Shares withheld for tax 30,849 $4.88 $150.5K Form 4
August 26, 2026 Faltischek Denise MChief Strategy Officer Exercised options 120,017 - - Form 4
August 26, 2026 Faltischek Denise MChief Strategy Officer Shares withheld for tax 63,610 $4.88 $310.4K Form 4
August 26, 2026 Gendel MitchellGlobal General Counsel Exercised options 50,556 - - Form 4
August 26, 2026 Gendel MitchellGlobal General Counsel Shares withheld for tax 26,795 $4.88 $130.8K Form 4
August 26, 2026 Gendel MitchellGlobal General Counsel Exercised options 109,748 - - Form 4
August 26, 2026 Gendel MitchellGlobal General Counsel Shares withheld for tax 58,167 $4.88 $283.9K Form 4
August 26, 2026 Merton Carl AChief Financial Officer Exercised options 57,380 - - Form 4
August 26, 2026 Merton Carl AChief Financial Officer Shares withheld for tax 31,559 $4.88 $154K Form 4
August 26, 2026 Merton Carl AChief Financial Officer Exercised options 111,072 - - Form 4
August 26, 2026 Merton Carl AChief Financial Officer Shares withheld for tax 61,090 $4.88 $298.1K Form 4
August 26, 2026 Simon Irwin DPresident and CEO, Director Exercised options 408,605 - - Form 4
August 26, 2026 Simon Irwin DPresident and CEO, Director Shares withheld for tax 216,561 $4.88 $1.1M Form 4
August 26, 2026 Simon Irwin DPresident and CEO, Director Exercised options 803,563 - - Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about TLRY

What does Tilray Brands, Inc. do?

Tilray Brands, Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on NASDAQ under the ticker TLRY.

Is Tilray Brands, Inc. profitable?

No. In fiscal 2026 it reported a net loss of $121.4M on revenue of $915.5M.

How much revenue does Tilray Brands, Inc. make?

In fiscal 2026 Tilray Brands, Inc. reported revenue of $915.5M. That is 11.5% more than a year earlier.

When did Tilray Brands, Inc. last report?

Its most recent periodic report is the annual report (10-K) filed on July 28, 2026. It covers the period to May 31, 2026. Its newest filing of any kind is the preliminary proxy statement from September 18, 2026.

Similar companies

Compare TLRY with

Compare TLRY with any company

Follow TLRY

Get an email when Tilray Brands, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow TLRY: get an email when it files

Where the numbers come from

Financial figures are the values Tilray Brands, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.